Francisco Silva
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Francisco Silva
Earlier roles on record: Board Member at BioRestorative Therapies, Inc. (BRTX) until June 11, 2026. BioRestorative Therapies, Inc. reported in an 8-K filed September 11, 2026 that Francisco Silva resigned as Vice President of Research and Development, effective September 4, 2026. BioRestorative Therapies, Inc. reported in an 8-K filed June 12, 2026 that Francisco Silva resigned as director, effective June 11, 2026. The proxy statement of BioRestorative Therapies, Inc. reports total compensation of $1,227,083 for Francisco Silva in fiscal 2024, including a base salary of $514,583. Disclosed compensation is on record for 6 fiscal years.
“On September 4, 2026, BioRestorative Therapies, Inc. (the "Company") received a notice of resignation from Mr. Silva from his employment with the Company, including as the Company's Vice President of Research and Development, and from each other position (if any) he held as an officer of the Company, effective immediately.”
“Effective June 11, 2026, pursuant to the Revolving Loan Agreement, Francisco Silva, Nickolay Kukekov and Patrick F. Williams resigned as directors of the Company.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
2020-01-01–2026-06-11
-
BioRestorative Therapies, Inc. (BRTX)
Source not stated
Start not stated–2026-09-04
Company network
Recorded roles and call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | BioRestorative Therapies, Inc. (BRTX) | VP, Research and Development | $514,583 | $1,227,083 |
| 2023 | BioRestorative Therapies, Inc. (BRTX) | VP, Research and Development | $454,167 | $1,204,167 |
| 2022 | BioRestorative Therapies, Inc. (BRTX) | VP, Research and Development | $375,000 | $427,364 |
| 2021 | BioRestorative Therapies, Inc. (BRTX) | VP, Research and Development | $259,375 | $21,325,864 |
| 2020 | BioRestorative Therapies, Inc. (BRTX) | VP, Research and Development | $207,553 | $207,553 |
| 2019 | BioRestorative Therapies, Inc. (BRTX) | VP, Research and Development | $287,500 | $287,500 |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.